Lead differentially modifies cytokine production in vitro and in vivo

被引:183
作者
Heo, Y
Parsons, PJ
Lawrence, DA
机构
[1] NEW YORK STATE DEPT HLTH,WADSWORTH CTR,ALBANY,NY 12201
[2] SUNY ALBANY,SCH PUBL HLTH,ALBANY,NY 12201
关键词
D O I
10.1006/taap.1996.0108
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
An imbalance between helper T cell type 1 (Th1) and helper T cell type 2 (Th2) activation can result in immunodysregulations leading to impaired cell-mediated immunity with an increased incidence of infectious disease or cancer and/or aberrant humoral immunity that may culminate with an autoimmune disease. Mercury, a heavy-metal toxicant, is known to induce renal autoimmunity characterized by a predominant Th2 response. Lead, another metal toxicant, causes enhanced B cell activities and impairs host resistance to several bacterial and viral infections. In addition, Pb was reported to enhance Th2 proliferation and inhibit Th1 proliferation. The differential effects of Pb on Th subset activation have been further investigated. In vitro IL-4 production by a Th2 clone was significantly increased by the addition of PbCl2, whereas IFN gamma production by a Th1 clone was decreased by the addition of PbCl2. When BALB/c mice were subcutaneously exposed to PbCl2, ex vivo IL-4 production by anti-CD3-stimulated splenic T cells was enhanced, but IFN gamma production was inhibited. Additionally, the plasma IL-4 and IgE levels of Pb-exposed mice were increased, and the plasma IFN gamma levels were significantly lowered in the absence of any additional exogenous antigen. In vitro, ex vivo, and in vivo treatment with HgCl2 produced similar findings. This study is the first report of the preferential activation of a Th2 response by Pb in vivo and suggests that Pb, like Hg, may induce autoimmune responses by upsetting the balance between Th1- and Th2-like cells, which could enhance production of antibodies to Self antigens. (C) 1996 Academic Press, Inc.
引用
收藏
页码:149 / 157
页数:9
相关论文
共 60 条
[1]  
[Anonymous], METAL TOXICOLOGY
[2]  
BARAN D, 1988, CLIN EXP IMMUNOL, V73, P401
[3]  
BELILES RP, 1994, PATTYS IND HYGIENE T, P2065
[4]   TRANSPORT-PROPERTIES OF OLIGOMERIC SUBUNIT STRUCTURES [J].
BERNAL, JMG ;
DELATORRE, JG .
BIOPOLYMERS, 1981, 20 (01) :129-139
[5]   IMPROVEMENT OF TH1 FUNCTIONS DURING THE REGULATION PHASE OF MERCURY DISEASE IN BROWN-NORWAY RATS [J].
CASTEDO, M ;
PELLETIER, L ;
PASQUIER, R ;
DRUET, P .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1994, 39 (02) :144-150
[6]   CHANGES IN INTERLEUKIN-2 AND INTERLEUKIN-4 PRODUCTION IN ASYMPTOMATIC, HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE INDIVIDUALS [J].
CLERICI, M ;
HAKIM, FT ;
VENZON, DJ ;
BLATT, S ;
HENDRIX, CW ;
WYNN, TA ;
SHEARER, GM .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (03) :759-765
[7]   ROLE OF CYTOKINES IN THE DIFFERENTIATION OF CD4+ T-CELL SUBSETS INVIVO [J].
COFFMAN, RL ;
VARKILA, K ;
SCOTT, P ;
CHATELAIN, R .
IMMUNOLOGICAL REVIEWS, 1991, 123 :189-207
[8]   FC-EPSILON-RII/CD23 - THE LOW AFFINITY RECEPTOR FOR IGE [J].
CONRAD, DH .
ANNUAL REVIEW OF IMMUNOLOGY, 1990, 8 :623-645
[9]  
COOK JA, 1975, P SOC EXP BIOL MED, V150, P741, DOI 10.3181/00379727-150-39117
[10]  
DUBEY C, 1991, CLIN EXP IMMUNOL, V86, P118